Kao C - Search Results

1

NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen.

Lee SJ, Lee K, Yang X, Jung C, Gardner T, Kim HS, Jeng MH, Kao C. Lee SJ, et al. Among authors: kao c. J Mol Biol. 2003 Jul 18;330(4):749-60. doi: 10.1016/s0022-2836(03)00640-5. J Mol Biol. 2003. PMID: 12850144

2

Novel prostate-specific promoter derived from PSA and PSMA enhancers.

Lee SJ, Kim HS, Yu R, Lee K, Gardner TA, Jung C, Jeng MH, Yeung F, Cheng L, Kao C. Lee SJ, et al. Among authors: kao c. Mol Ther. 2002 Sep;6(3):415-21. doi: 10.1006/mthe.2002.0682. Mol Ther. 2002. PMID: 12231179 Free article.

3

Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer.

Lee SJ, Zhang Y, Lee SD, Jung C, Li X, Kim HS, Bae KH, Jeng MH, Kao C, Gardner T. Lee SJ, et al. Among authors: kao c. Mol Ther. 2004 Dec;10(6):1051-8. doi: 10.1016/j.ymthe.2004.08.028. Mol Ther. 2004. PMID: 15564137 Free article.

4

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.

Li X, Zhang YP, Kim HS, Bae KH, Stantz KM, Lee SJ, Jung C, Jiménez JA, Gardner TA, Jeng MH, Kao C. Li X, et al. Among authors: kao c. Cancer Res. 2005 Mar 1;65(5):1941-51. doi: 10.1158/0008-5472.CAN-04-3666. Cancer Res. 2005. PMID: 15753394

5

Prostate cancer gene therapy: past experiences and future promise.

Gardner TA, Sloan J, Raikwar SP, Kao C. Gardner TA, et al. Among authors: kao c. Cancer Metastasis Rev. 2002;21(2):137-45. doi: 10.1023/a:1020875925685. Cancer Metastasis Rev. 2002. PMID: 12465753 Review.

6

Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation.

Liu Y, Kim BO, Kao C, Jung C, Dalton JT, He JJ. Liu Y, et al. Among authors: kao c. J Biol Chem. 2004 May 21;279(21):21766-73. doi: 10.1074/jbc.M314321200. Epub 2004 Mar 18. J Biol Chem. 2004. PMID: 15031286 Free article.

7

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.

Hong H, Kao C, Jeng MH, Eble JN, Koch MO, Gardner TA, Zhang S, Li L, Pan CX, Hu Z, MacLennan GT, Cheng L. Hong H, et al. Among authors: kao c. Cancer. 2004 Jul 1;101(1):83-9. doi: 10.1002/cncr.20327. Cancer. 2004. PMID: 15221992 Free article.

8

Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.

Raikwar SP, Temm CJ, Raikwar NS, Kao C, Molitoris BA, Gardner TA. Raikwar SP, et al. Among authors: kao c. Mol Ther. 2005 Dec;12(6):1091-100. doi: 10.1016/j.ymthe.2005.07.690. Epub 2005 Oct 5. Mol Ther. 2005. PMID: 16169279 Free PMC article.

9

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter.

Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH. Li X, et al. Among authors: kao c. Mol Cancer Ther. 2005 Dec;4(12):1850-9. doi: 10.1158/1535-7163.MCT-05-0167. Mol Cancer Ther. 2005. PMID: 16373700

10

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.

Li X, Raikwar SP, Liu YH, Lee SJ, Zhang YP, Zhang S, Cheng L, Lee SD, Juliar BE, Gardner TA, Jeng MH, Kao C. Li X, et al. Among authors: kao c. Mol Cancer Ther. 2006 Mar;5(3):676-84. doi: 10.1158/1535-7163.MCT-05-0339. Mol Cancer Ther. 2006. PMID: 16546982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,553 results

Search Page

Filters